Day: January 5, 2021

Doctor says Stormont’s latest COVID clinical trial proving successful,

TOPEKA, Kan. (WIBW) – Stormont Vail has been participating in clinical trials for new COVID treatments since the start of the pandemic. In fact …, TOPEKA, Kan. (WIBW) – Stormont Vail has been participating in clinical trials for new COVID treatments since the start of the pandemic. In fact …, Read More

Inventiva announces design of Phase III clinical trial with lanifibranor in NASH,

A single global Phase III clinical trial evaluating two doses of lanifibranor (800mg and 1200mg once daily) versus placebo is intended to support U.S. New Drug Application (NDA) / EU …, A single global Phase III clinical trial evaluating two doses of lanifibranor (800mg and 1200mg once daily) versus placebo is intended to support U.S. …

Inventiva announces design of Phase III clinical trial with lanifibranor in NASH, Read More »

Inventiva announces design of Phase III clinical trial with lanifibranor in NASH,

A single global Phase III clinical trial evaluating two doses of lanifibranor (800mg and 1200mg once daily) versus placebo is intended to support U.S. New Drug Application (NDA) / EU …, A single global Phase III clinical trial evaluating two doses of lanifibranor (800mg and 1200mg once daily) versus placebo is intended to support U.S. …

Inventiva announces design of Phase III clinical trial with lanifibranor in NASH, Read More »

Inventiva announces design of Phase III clinical trial with lanifibranor in NASH,

A single global Phase III clinical trial evaluating two doses of lanifibranor (800mg and 1200mg once daily) versus placebo is intended to support U.S. New Drug Application (NDA) / EU …, A single global Phase III clinical trial evaluating two doses of lanifibranor (800mg and 1200mg once daily) versus placebo is intended to support U.S. …

Inventiva announces design of Phase III clinical trial with lanifibranor in NASH, Read More »

Scroll to Top